BiondVax Pharmaceuticals Ltd. – NASDAQ:BVXV

Add to watchlist

Market closed

Open in 2 days

-1.45%

month

-25.27%

quarter

+32.55%

year

Market Cap	4.96M
Enterprise value	35.86M

P/E	-0.4
EV/Sales	N/A
EV/EBITDA	-2.59
Price/Sales	N/A
Price/Book	1.16
PEG ratio	-0.05
EPS	N/A

Revenue	N/A
EBITDA	-5.00M
Income	7.78M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Profit margin
Sep 2022	0	9.79M
Dec 2022	0	5.59M
Mar 2023	2.01M	-3.84M	-190.67%
Jun 2023	0	-3.76M

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Earnings per share (EPS)
2022-06-01	-4	-2
2022-08-25	-0.40005	-2.1
2022-11-30	-0.006	0.06
2023-04-17	-0.3	-0.3

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Debt to assets
Sep 2022	74717000	65.35M	87.47%
Dec 2022	27067000	28.82M	106.5%
Mar 2023	23292000	28.10M	120.65%
Jun 2023	19897000	27.00M	135.74%

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Cash Flow
Jun 2022	-10.40M	-84K	-468K
Dec 2022	15.85M	-483K	-25.80M
Mar 2023	-3.05M	-6K	0
Jun 2023	-2.87M	-377K	0

BiondVax Pharmaceuticals Ltd. alternative data

BiondVax Pharmaceuticals Ltd.
Employees

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV): Employee count
Aug 2023	33
Sep 2023	33
Oct 2023	33
Nov 2023	33
Dec 2023	33
Jan 2024	33
Feb 2024	33
Mar 2024	33
Apr 2024	33
May 2024	33
Jun 2024	33
Jul 2024	33

BiondVax Pharmaceuticals Ltd.
Hedge Funds Holdings Q1 2023

0.00% -0.32%

of BVXV is owned by hedge funds

7 -3

hedge funds hold BVXV stock

16.48K -225.56K

shares is hold by hedge funds

BVXV hedge funds holdings changes

BiondVax Pharmaceuticals Ltd.
Patents

Status	Patent	Filling date	Issue date
Application	Application COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION Filling date: 27 Aug 2019 Issue date: 2 Jan 2020	27 Aug 2019	2 Jan 2020

BVXV patents

BiondVax Pharmaceuticals Ltd.
Earnings Call Transcripts

Quarter	Transcript
Q4 2021 4 Apr 2022	Q4 2021 Earnings Call Transcript

BVXV earnings call transcripts

BiondVax Pharmaceuticals Ltd.
Latest News

Wednesday, 6 September 2023
06:00	BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd.	globenewswire.com
Friday, 11 August 2023
09:00	BiondVax Reports Second Quarter Financial Results and Provides Business Update	globenewswire.com
Tuesday, 1 August 2023
16:01	Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules	globenewswire.com
Thursday, 16 March 2023
13:10	BiondVax to Present at BIO-Europe Spring	GlobeNewsWire
Thursday, 2 February 2023
14:15	BiondVax Presenting at BIO CEO & Investor Conference	GlobeNewsWire
Monday, 23 January 2023
09:28	Best Penny Stocks To Buy? 5 To Watch After Big News This Week	PennyStocks
Monday, 21 November 2022
06:00	BiondVax CEO to Present at the January 2023 Biotech Showcase in San Francisco	PRNewsWire
Thursday, 3 November 2022
11:30	BiondVax to present at Recent Advances in Fermentation Technology (RAFT) 14 Conference	PRNewsWire
Tuesday, 18 October 2022
07:55	BiondVax to Present at LD Micro Investor Conference in Los Angeles	Newsfile Corp
Tuesday, 11 October 2022
14:00	BiondVax to present at LD Micro Investor Conference in Los Angeles	PRNewsWire
Thursday, 8 September 2022
09:13	BiondVax to Present at H.C. Wainwright 24th Annual Global Investment Conference	PRNewsWire
Monday, 9 May 2022
06:00	BiondVax to Present at this week's Biomed Israel Conference	PRNewsWire
Monday, 4 April 2022
15:23	BiondVax Pharmaceuticals Ltd. (BVXV) CEO Amir Reichman on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Thursday, 24 March 2022
13:15	Why Is BiondVax (BVXV) Stock Up Today?	InvestorPlace
12:03	Here's Why Biondvax Pharmaceuticals Shares Are Rising	Benzinga
09:31	Trading Penny Stocks? Top Stock Market News for March 24th, 2022	PennyStocks
Tuesday, 22 February 2022
08:44	BiondVax to Present at Aegis Virtual Conference	PRNewsWire
Tuesday, 15 February 2022
08:31	BiondVax to Present at BIO CEO & Investor Conference	PRNewsWire
Wednesday, 26 January 2022
07:39	BiondVax to Present at Edison Group's Open House Conference	PRNewsWire
Tuesday, 28 December 2021
09:42	Hot Penny Stocks to Watch During the Santa Claus Rally	PennyStocks
08:06	Biondvax Pharmaceuticals Stock (BVXV): Why The Price Surged Today	Pulse2
Wednesday, 22 December 2021
11:29	BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pharma Soaring	InvestorPlace
09:40	Hot Penny Stocks to Buy Now? 3 For Your New Years Watchlist	PennyStocks
08:00	Biondvax Pharmaceuticals Stock (BVXV): Why The Price Surged Today	Pulse2
Tuesday, 30 November 2021
10:43	Biondvax Pharmaceuticals (BVXV) Stock: Why The Price Fell Today	Pulse2
Monday, 15 November 2021
05:15	BiondVax to Present at H.C. Wainwright 7th Annual Israel Conference	PRNewsWire
Tuesday, 19 October 2021
07:53	BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies	PRNewsWire
Thursday, 26 August 2021
16:05	BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update	PRNewsWire

Frequently Asked Questions (FAQ)

When is BiondVax Pharmaceuticals Ltd.'s next earnings date?

Unfortunately, BiondVax Pharmaceuticals Ltd.'s (BVXV) next earnings date is currently unknown.
Does BiondVax Pharmaceuticals Ltd. pay dividends?

No, BiondVax Pharmaceuticals Ltd. does not pay dividends.
How much money does BiondVax Pharmaceuticals Ltd. make?

BiondVax Pharmaceuticals Ltd. has a market capitalization of 4.96M. BiondVax Pharmaceuticals Ltd. made a loss 531K US dollars in net income (profit) last year or -$0.3 on an earnings per share basis.
What is BiondVax Pharmaceuticals Ltd.'s stock symbol?

BiondVax Pharmaceuticals Ltd. is traded on the NASDAQ under the ticker symbol "BVXV".
What is BiondVax Pharmaceuticals Ltd.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of BiondVax Pharmaceuticals Ltd.?

Shares of BiondVax Pharmaceuticals Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does BiondVax Pharmaceuticals Ltd. have?

As Jul 2024, BiondVax Pharmaceuticals Ltd. employs 33 workers.
When BiondVax Pharmaceuticals Ltd. went public?

BiondVax Pharmaceuticals Ltd. is publicly traded company for more then 10 years since IPO on 12 May 2015.
What is BiondVax Pharmaceuticals Ltd.'s official website?

The official website for BiondVax Pharmaceuticals Ltd. is biondvax.com.
How can i contact BiondVax Pharmaceuticals Ltd.?

BiondVax Pharmaceuticals Ltd. can be reached via phone at +972 8 930 2529.

BiondVax Pharmaceuticals Ltd.

biondvax.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

+972 8 930 2529

Jerusalem BioPark Building
Jerusalem,

CIK: 0001611747
ISIN: US09073Q1058
CUSIP: 09073Q105